Pfleiderer Stefan O R, Sachse Steffen, Sauner Dieter, Marx Christiane, Malich Ansgar, Wurdinger Susanne, Kaiser Werner A
Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University, Jena, Germany.
Breast Cancer Res. 2004;6(3):R232-8. doi: 10.1186/bcr779. Epub 2004 Mar 16.
The aim of the present article is to investigate effects of hormone replacement therapy (HRT) on contrast medium enhancement patterns in postmenopausal patients during magnetic resonance mammography (MRM).
Two hundred and fifteen patients receiving hormonal medication were divided into four groups: 150 patients with 1 MRM during HRT (group A), 13 patients with 2 MRMs under HRT (group B), 30 patients with 1 MRM during HRT and 1 MRM after HRT withdrawal (group C), and 22 women with 1 MRM after HRT withdrawal (group D). Dynamic MRM was performed at 1.5 Tesla. Signal intensity changes were characterized by five time curves: minimal enhancement (type I), weak continuous enhancement (type II), strong continuous enhancement (type III), and a steep initial slope followed by a plateau phenomenon (type IV) or a washout effect (type V).
Of all 193 patients under HRT (group A + group B + group C), 60 patients (31.1%) showed curve type I, 88 patients (45.6%) showed type II and 45 patients (23.3%) showed type III. There were significant differences to 52 patients after HRT withdrawal (group C + group D) (P < 0.0001), with 42 patients (80.8%) for curve type I, 8 patients (15.4%) for type II, and 2 patients (3.8%) for type III. In both MRM sessions in group B, 69% of the patients showed identical curve types without significant differences (P = 0.375). In group C, 28 of 30 patients (93%) dropped to lower curve types with significant differences in curve types during and after HRT (P < 0.0001).
The majority of patients receiving postmenopausal HRT showed bilateral symmetrical, continuous enhancement without evidence of a plateau phenomenon or a washout effect due to HRT in MRM. Hormonal effects could be proven and were reproducible and reversible.
本文旨在研究激素替代疗法(HRT)对绝经后患者在磁共振乳腺成像(MRM)期间造影剂增强模式的影响。
215例接受激素治疗的患者被分为四组:150例在HRT期间进行1次MRM检查的患者(A组),13例在HRT期间进行2次MRM检查的患者(B组),30例在HRT期间进行1次MRM检查且在停用HRT后进行1次MRM检查的患者(C组),以及22例在停用HRT后进行1次MRM检查的女性(D组)。在1.5特斯拉下进行动态MRM检查。信号强度变化通过五条时间曲线进行表征:最小增强(I型)、弱持续增强(II型)、强持续增强(III型),以及陡峭的初始斜率后接平台现象(IV型)或廓清效应(V型)。
在所有193例接受HRT的患者(A组+B组+C组)中,60例患者(31.1%)表现为I型曲线,88例患者(45.6%)表现为II型曲线,45例患者(23.3%)表现为III型曲线。与52例停用HRT后的患者(C组+D组)相比存在显著差异(P<0.0001),其中42例患者(80.8%)为I型曲线,8例患者(15.4%)为II型曲线,2例患者(3.8%)为III型曲线。在B组的两次MRM检查中,69%的患者表现出相同的曲线类型,无显著差异(P = 0.375)。在C组中,30例患者中有28例(93%)曲线类型降至更低,HRT期间和之后曲线类型存在显著差异(P<0.0001)。
大多数接受绝经后HRT的患者在MRM中表现出双侧对称、持续增强,且无因HRT导致的平台现象或廓清效应的证据。激素效应可被证实,且具有可重复性和可逆性。